23 November 2024NewsAmericasBetsy Haanes SVP, Intellectual Property IGM Biosciences, Theresa Raymer Head of Intellectual Property, Associate General Counsel and Senior Director IP Recor Medical, David Dolberg Senior Director of Intellectual Property Sanaria Inc

WATCH: Essential considerations: patenting and clinical trials

There is an intricate intersection between patenting and clinical trials within the dynamic IP landscape in the life sciences industries. Safeguarding your innovation throughout the research process is critical, necessitating a careful balance between the need to file and when to file, explain speakers from IGM Biosciences, IP Recor Medical, and Sanaria Inc.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
17 March 2026   Janssen seeks injunctive relief after a forensic review uncovers mass downloads of trade secrets spanning oncology, neuroscience and immunology portfolios.
Americas
13 March 2026   A proposed judgment by the rivals would extend the period in which Mylan is barred from obtaining regulatory approval for its generic of the weight-loss injectable.
Americas
12 March 2026   The event unpacked how technology, litigation trends, and global events are adding complexity while also offering benefits for legal teams under pressure to reduce costs.